475995 Sigma-AldrichInhibitorSelect™ mTOR Signaling Regulators Panel - Calbiochem
Empfohlene Produkte
Übersicht
| Replacement Information |
|---|
| Description | |
|---|---|
| Overview | This product has been discontinued. A panel containing 17 potent and selective small molecule regulators that is useful for the study of mTOR signaling: 1 mg of Akt Inhibitor VIII, Isozyme-Selective, Akti-1/2 (Cat. No. 124018), 10 mg of Akt Inhibitor XVI, AT7867 (Cat. No. 124033), 1 mg of AMPK Inhibitor, Compound C (Cat. No. 171260), 10 mg of bpV(phen) (Cat. No. 203695), 5 mg of Compound 401 (Cat. No. 234501), 1 mg of H-89, Dihydrochloride (Cat. No. 371963), 5 mg of mTOR Inhibitor III, PP242 (Cat. No. 475988), 5 mg of mTOR Inhibitor IV, Ku-63794 (Cat. No. 475990), 5 mg of PDK1 Inhibitor II, BX-517 (Cat. No. 521276), 1 mg of PI-103 (Cat. No. 528100), 1 mg of PI 3-Kβ Inhibitor VI, TGX-221 (Cat. No. 528113), 5 mg of PTK/PI 3-K/mTOR Inhibitor, PP121 (Cat. No. 529584), 1 mg of Rapamycin (Cat. No. 553210), 10 mg of S6K1 Inhibitor, PF-4708671 (Cat. No. 559273), 10 mg of SHIP1 Inhibitor, 3AC (Cat. No. 565835), 10 mg of SHIP2 Inhibitor, AS1938909 (Cat. No. 565840), 1 mg of U0126 (Cat. No. 662005). Also provided with 15 ml of anhydrous DMSO (Cat. No. KP31817). Supplied with a data sheet. |
| Catalogue Number | 475995 |
| Brand Family | Calbiochem® |
| Product Information | |
|---|---|
| Form | Solid |
| Quality Level | MQ100 |
| Applications |
|---|
| Biological Information |
|---|
| Physicochemical Information |
|---|
| Dimensions |
|---|
| Materials Information |
|---|
| Toxicological Information |
|---|
| Safety Information according to GHS |
|---|
| Safety Information |
|---|
| Product Usage Statements |
|---|
| Packaging Information | |
|---|---|
| Packaged under inert gas | Packaged under inert gas |
| Transport Information |
|---|
| Supplemental Information |
|---|
| Specifications |
|---|
| Global Trade Item Number | |
|---|---|
| Bestellnummer | GTIN |
| 475995 | 0 |
Documentation
Literatur
| Übersicht |
|---|
| Zoncu, R., et al. 2011. Nat. Rev. Mol. Cell Biol. 12, 21. Foster, K.G. and Fingar, D.C., 2010. J. Biol. Chem. 285, 14071. Albert, S., et al. 2010. Expert Opin. Investing Drugs 19, 919. Hoeffer, C.A. and Klann, E., 2010. Trends Neurosci. 33, 67. Laplante, M. and Sabatini, D.M., 2009. J. Cell Sci. 122, 3589. Meric-Bernstam, F. and Gonzalez-Angulo, A.M., 2009. J. Clin. Oncol. 27, 2278. Faivre, S., et al. 2006. Nat. Rev. Drug Discov. 5, 671. |